The results support the hypothesis that high methylation of RASSF1‐1α, indicating reduced RASSF1A expression, is moderately associated with poor breast cancer outcome (P = 0.045, log‐rank test) (Fig 6B). This evidence concerns the gene RASSF1 and breast carcinoma.